PRESTIGE CONSUMER HEALTHCARE INC (PBH)
Health Care · Over-the-counter (OTC) consumer healthcare products · NYSE
Prestige Consumer Healthcare is a branded over-the-counter consumer health products company focused on eye care, pain relief, and other wellness categories with a portfolio of established brands.
What PRESTIGE CONSUMER HEALTHCARE INC does
Prestige Consumer Healthcare Inc. manufactures and distributes a portfolio of over-the-counter (OTC) consumer healthcare products, primarily through third-party manufacturers. The company focuses on branded products in categories including eye care, pain relief, and other health and wellness segments sold through retail and e-commerce channels. Prestige relies on a network of approximately 95 third-party manufacturers, with 18 long-term contract manufacturers accounting for roughly 60% of gross sales, creating significant supply chain concentration risk that has resulted in product shortages and inventory challenges.
Themes: ["OTC consumer healthcare","Eye care","Pain relief","Supply chain and manufacturing risk"]
Fundamentals
- Price$48.48 as of 2026-07-09 close
- Market cap$2.3B as of 2026-07-10
- 1-year return-38.5% as of 2026-07-09 close
- P/E12.07 as of 2026-07-10
- Net margin+17.5% as of 2026-07-10
- Gross margin+54.7% as of 2026-07-10
- ROE+10.3% as of 2026-07-10
- Debt / equity0.54 as of 2026-07-10
- Revenue growth (YoY)-4.3% as of 2026-07-10
- Revenue CAGR (3y)-1.2% SEC XBRL
- Beta0.33 as of 2026-07-10
Key risks (from latest filing)
["Critical supply chain concentration: 18 manufacturers with long-term contracts account for ~60% of gross sales; one supplier represents 21% of revenues, and manufacturing shortages—particularly in eye care products—have negatively impacted sales and are expected to continue impacting results.","Third-party manufacturer dependence: Unable to timely qualify alternative suppliers or transfer production to own facilities without significant delay, expense, and regulatory complications; one supplier discontinued operations without repaying a $10.3 million short-term loan in fiscal 2026.","Margin pressure from input costs: Price increases in raw materials, packaging, labor, energy, and transportation, along with manufacturer and logistics demands, are expected to continue adversely impacting gross margins."]
Competitors & peers
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.